Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review
- PMID: 34659743
- PMCID: PMC8500694
- DOI: 10.1016/j.amsu.2021.102898
Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review
Abstract
This systematic review summarizes the evidence on patients diagnosed with central retinal vein occlusion (CRVO) secondary to COVID-19. We searched PubMed and Google Scholar from its inception till June 2021. From an initial 55 publications, 10 studies provided specific information on COVID-19 patients with CRVO. Studies described 10 patients, 60% were male and the mean age was 39.3 ± 11.6 years. Blurred vision (40%) and decreased vision (50%) were the most common presenting complain. Symptom onset ranged from 5 days to 6 weeks after initial complaint of fever. Laboratory results showed elevated inflammatory markers and D-dimers in 60% of patients included in our review. Common treatment options were intravitreal anti-VEGF injections, steroids, and anticoagulants. Traditional co-morbidities like diabetes mellites, hypertension, and morbid obesity (hyperlipidemia) were observed in only 3/10 patients. The prognosis was excellent as all patients saw improvement in their condition. Our findings highlight the importance of identifying CRVO as an important complication of COVID-19 infection. Thus, physicians should not overlook the likelihood of CRVO in patients with COVID-19 infection and offer prompt treatment.
Keywords: COVID-19; CRVO; Central retinal vein occlusion; Pandemic.
© 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
Conflict of interest statement
None.
References
-
- Weekly epidemiological update on COVID-19 - 10 August 2021 [internet]. World health organization. 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on... [cited 2021 Aug 15]. Available from.
-
- Terpos E., Ntanasis-Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T.N., Politou M., et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020 Jul 1 https://pubmed.ncbi.nlm.nih.gov/32282949/ [Internet] [cited 2021 Aug 15];95(7):834–47. Available from: - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
